Hamps Bio Ltd Posts Loss in FY2026 Amidst Revenue Growth and Acquisition

For the year ended March 31, 2026, Hamps Bio Ltd reported a standalone net loss of ₹0.65 crore, a significant shift from a profit of ₹0.30 crore in the previous fiscal year. Consolidated net loss stood at ₹0.74 crore.

Reader Takeaway: Revenue grew, but costs led to a loss; acquisition impact is key.

What just happened

Hamps Bio Ltd announced its audited standalone and consolidated financial results for the year ended March 31, 2026. The company reported a standalone revenue of ₹8.52 crore, an increase from ₹6.67 crore in FY2025. However, this top-line growth did not translate to profitability, with the company posting a standalone net loss of ₹0.65 crore compared to a profit of ₹0.30 crore in the prior year. Consolidated revenue was ₹8.47 crore with a net loss of ₹0.74 crore.

Why this matters

The swing from profit to loss is a key concern for investors, indicating potential issues with cost management or margin pressure despite revenue expansion. The company also completed a significant acquisition and utilized its IPO funds, signalling strategic shifts that will impact future performance.

The backstory

Hamps Bio Ltd had previously reported profits. The fiscal year 2026 results mark a reversal in profitability. The company also undertook corporate actions including a 1:1 bonus share issue approved in August 2025 and the full utilization of IPO proceeds towards stated objectives.

What changes now

With the acquisition of HSDL Innovative Private Limited (now a wholly-owned subsidiary) and the deployment of IPO funds, Hamps Bio Ltd is entering a new operational phase. Investors will be watching how these strategic moves influence future financial performance and profitability.

Risks to watch

A significant watch point is the company's inability to compute segment profit or loss without arbitrary allocations, as stated in the financial notes. This lack of granular segment data limits insight into the profitability drivers within the business.

Peer comparison

Information regarding specific peers and their comparative financial performance is not available in the provided filing.

Context metrics (time-bound)

• Revenue from Operations (Standalone): FY2026 ₹8.52 crore vs FY2025 ₹6.67 crore.
• Profit/(Loss) After Tax (Standalone): FY2026 ₹(0.65) crore vs FY2025 ₹0.30 crore.
• Acquisition: 100% stake in HSDL Innovative Private Limited acquired on March 25, 2026.
• Bonus Shares: 1:1 ratio issued in August 2025.

What to track next

Investors should closely monitor the integration and performance of HSDL Innovative Private Limited, the effectiveness of the company's cost management strategies, and the overall profitability trajectory in the upcoming financial quarters.